Relative Bioavailability and Food Effect Study With Vericiguat to Characterize the Pediatric Formulation in Adult Healthy Subjects

Inclusion Criteria: * Healthy male subject * Age: 18 to 45 years (inclusive) at informed consent * Race: white * Body Mass Index (BMI): above or equal 18.0 and below or equal 29.9 kg / m² Exclusion Criteria: * Incompletely cured pre-existing diseases for which it can be assumed that the absorption, distribution, metabolism, elimination and effects of the study drugs will not be normal * Known hypersensitivity to the study drugs (active substances or excipients of the preparations) * Known severe allergies, non-allergic drug reactions, or multiple drug allergies * Febrile illness within 1 week prior to the first study drug administration * History of postural syncopes * A history of relevant diseases of vital organs, of the central nervous system or other organs * A history of relevant smell and / or taste disorders * Relevant diseases within the last 4 weeks prior to the first study drug administration * Medical disorder that would impair the subject's ability to complete the study in the opinion of the investigator. * Known gastro-intestinal disorders (e.g. stomach ulcers, duodenal ulcers, gastrointestinal bleeding) or inflammatory bowel disease (e.g. Crohn's disease, ulcerative colitis)